Advertisement

Latest News

Telemedicine at Syringe Access Programs May Address Barriers, Expand Access to HCV Treatment

4 minutes ago

A recent survey found telemedicine-based HCV treatment at a syringe access program could improve access to treatment among people who inject drugs.

Erectile Dysfunction Drug Lacks Effect on AMD Prevention, Study Finds

13 hours ago

A cohort analysis in the UK observed no significant association between sildenafil use and AMD prevention in men with erectile dysfunction.

Anemia Exhibits Limited Association with Early Childhood Development

14 hours ago

A cross-sectional analysis of nine low- and middle-income countries revealed few statistically significant associations between anemia and early childhood development.

Stephen Harrison, MD: The Role of Weight Loss, Resmetirom in NASH Management

16 hours ago

Harrison discusses the role of GLP-1-based therapies in NASH management and situations where resmetirom may be a better option following its recent FDA approval.

Stephen Harrison, MD: FDA Approval of Resmetirom Ends Lengthy Road to First NASH Treatment

16 hours ago

Harrison discusses important lessons from obeticholic acid’s FDA failure and what set resmetirom apart from its predecessor, poising it to become the first FDA-approved NASH treatment.

Advertisement
Advertisement